Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)

Market Cap	24.38B -19.6%
Revenue (ttm)	24.51B +1.7%
Net Income	1.73B +10.0%
EPS	1.40 +10.2%
Shares Out	1.21B
PE Ratio	14.36
Forward PE	12.67
Dividend	0.70 (3.48%)
Ex-Dividend Date	Jun 25, 2026

Volume	10,694,620
Open	20.15
Previous Close	20.11
Day's Range	19.99 - 20.79
52-Week Range	17.68 - 26.56
Beta	0.38
Analysts	Buy
Price Target	33.22 (+60.79%)
Earnings Date	Aug 28, 2026

About Yifeng Pharmacy Chain

Yifeng Pharmacy Chain Co., Ltd. engages in the retail business of pharmaceutical products in China. The company operates through Retail business and Wholesale business segments. The company offers Western and Chinese patent medicine, traditional Chinese medicine herbal pieces, medical devices and equipment, health supplements and products, personal care products, drugs, and convenience products related to health. It is also involved in chronic disease management, medical project investment, and medical technology development, as well as operate...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2001
• Employees: 38,953
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603939

Financial Performance

In 2025, Yifeng Pharmacy Chain's revenue was 24.43 billion, an increase of 1.54% compared to the previous year's 24.06 billion. Earnings were 1.68 billion, an increase of 9.81%.

Analyst Summary

According to 15 analysts, the average rating for 603939 stock is "Buy." The 12-month stock price target is ¥33.22, which is an increase of 60.79% from the latest price.

Price Target

¥33.22

(60.79% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 13, 2026

Data Sources Report a data error